The present study was undertaken to determine the efficacy of ketoconazole in comparison to sodium antimony gluconate (SAG) in the treatment of kala-azar. The study was conducted at two centres: All India Institute of Medical Science, New Delhi and Calcutta School of Tropical Medicine, Calcutta.
J P, Wali +8 more
openaire +1 more source
Takayasu Arteritis Coexisting with Cutaneous Leishmaniasis. [PDF]
Zhao M +7 more
europepmc +1 more source
Análisis de costo-efectividad de la Termoterapia, en comparación con el Glucantime, para el tratamiento de pacientes con Leishmaniasis cutánea en Colombia 2015 [PDF]
Introducción: Leishmaniasis cutánea genera una elevada carga de la enfermedad en Colombia y los tratamientos disponibles presentan toxicidad sistémica, baja adherencia, contraindicaciones y alto costo -- Objetivo: Estimar la de costo-efectividad de la ...
Cardona Arias, Jaiberth Antonio
core
Drugs used in PKDL include parenteral sodium antimony gluconate (SAG), amphotericin-B, pentamidine, and ketoconazole (KTZ). SAG is the most effective one. Given alone, SAG has to be given for a long duration, leading to poor patient compliance and treatment failure.
S. K. Rathi +3 more
openaire +1 more source
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective [PDF]
core +1 more source
Effect of sodium stibogluconate in recruiting and awakening immune cells in the pleural fluid of pancreatic cancer: preparation for immunotherapy. [PDF]
Yu B +5 more
europepmc +1 more source
Case report: Diagnosis of visceral leishmaniasis using metagenomic next-generation sequencing and bone marrow smear. [PDF]
Zhang X +8 more
europepmc +1 more source
Integrated diagnosis and successful treatment of imported old world cutaneous leishmaniasis with intralesional sodium stibogluconate in china: a case report. [PDF]
Xu J, Xia X, Liu Z.
europepmc +1 more source
Clinical analysis of secondary hemophagocytic syndrome in children in Gansu province. [PDF]
Zhou Y, Yang J, Tao Z.
europepmc +1 more source

